Literature DB >> 24614839

The CSF3R T618I mutation as a disease-specific marker of atypical CML post allo-SCT.

S E Langabeer1, S L McCarron1, K Haslam1, M T O'Donovan2, E Conneally2.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2014        PMID： 24614839     DOI： 10.1038/bmt.2014.35

Source DB:  PubMed          Journal:  Bone Marrow Transplant        ISSN： 0268-3369            Impact factor:   5.483


× No keyword cloud information.
  9 in total

1.  Impact of JAK2V617F mutation status, allele burden, and clearance after allogeneic stem cell transplantation for myelofibrosis.

Authors:  Haefaa Alchalby; Anita Badbaran; Tatjana Zabelina; Guido Kobbe; Joachim Hahn; Daniel Wolff; Martin Bornhäuser; Christian Thiede; Herrad Baurmann; Wolfgang Bethge; York Hildebrandt; Ulrike Bacher; Boris Fehse; Axel R Zander; Nicolaus Kröger
Journal:  Blood       Date:  2010-05-20       Impact factor: 22.113

2.  Identification of risk factors in atypical chronic myeloid leukemia.

Authors:  Massimo Breccia; Francesca Biondo; Roberto Latagliata; Ida Carmosino; Franco Mandelli; Giuliana Alimena
Journal:  Haematologica       Date:  2006-10-17       Impact factor: 9.941

3.  Outcome of hematopoietic stem cell transplantation in patients with atypical chronic myeloid leukemia.

Authors:  M Koldehoff; D W Beelen; R Trenschel; N K Steckel; R Peceny; M Ditschkowski; H Ottinger; A H Elmaagacli
Journal:  Bone Marrow Transplant       Date:  2004-12       Impact factor: 5.483

4.  Recurrent SETBP1 mutations in atypical chronic myeloid leukemia.

Authors:  Rocco Piazza; Simona Valletta; Nils Winkelmann; Sara Redaelli; Roberta Spinelli; Alessandra Pirola; Laura Antolini; Luca Mologni; Carla Donadoni; Elli Papaemmanuil; Susanne Schnittger; Dong-Wook Kim; Jacqueline Boultwood; Fabio Rossi; Giuseppe Gaipa; Greta P De Martini; Paola Francia di Celle; Hyun Gyung Jang; Valeria Fantin; Graham R Bignell; Vera Magistroni; Torsten Haferlach; Enrico Maria Pogliani; Peter J Campbell; Andrew J Chase; William J Tapper; Nicholas C P Cross; Carlo Gambacorti-Passerini
Journal:  Nat Genet       Date:  2012-12-09       Impact factor: 38.330

5.  CSF3R T618I is a highly prevalent and specific mutation in chronic neutrophilic leukemia.

Authors:  A Pardanani; T L Lasho; R R Laborde; M Elliott; C A Hanson; R A Knudson; R P Ketterling; J E Maxson; J W Tyner; A Tefferi
Journal:  Leukemia       Date:  2013-04-22       Impact factor: 11.528

6.  JAK2-V617F-triggered preemptive and salvage adoptive immunotherapy with donor-lymphocyte infusion in patients with myelofibrosis after allogeneic stem cell transplantation.

Authors:  Nicolaus Kröger; Haefaa Alchalby; Evgeny Klyuchnikov; Anita Badbaran; York Hildebrandt; Francis Ayuk; Ulrike Bacher; Oliver Bock; Michael Kvasnicka; Boris Fehse; Axel Zander
Journal:  Blood       Date:  2009-02-19       Impact factor: 22.113

7.  Screening and monitoring of MPL W515L mutation with real-time PCR in patients with myelofibrosis undergoing allogeneic-SCT.

Authors:  H Alchalby; A Badbaran; O Bock; B Fehse; U Bacher; A R Zander; N Kröger
Journal:  Bone Marrow Transplant       Date:  2010-01-11       Impact factor: 5.483

8.  JAK2 p.V617F allele burden in myeloproliferative neoplasms one month after allogeneic stem cell transplantation significantly predicts outcome and risk of relapse.

Authors:  Thoralf Lange; Anja Edelmann; Udo Siebolts; Rainer Krahl; Claudia Nehring; Nadja Jäkel; Michael Cross; Jacqueline Maier; Dietger Niederwieser; Claudia Wickenhauser
Journal:  Haematologica       Date:  2013-01-08       Impact factor: 9.941

9.  Oncogenic CSF3R mutations in chronic neutrophilic leukemia and atypical CML.

Authors:  Julia E Maxson; Jason Gotlib; Daniel A Pollyea; Angela G Fleischman; Anupriya Agarwal; Christopher A Eide; Daniel Bottomly; Beth Wilmot; Shannon K McWeeney; Cristina E Tognon; J Blake Pond; Robert H Collins; Basem Goueli; Stephen T Oh; Michael W Deininger; Bill H Chang; Marc M Loriaux; Brian J Druker; Jeffrey W Tyner
Journal:  N Engl J Med       Date:  2013-05-09       Impact factor: 91.245
  9 in total
  8 in total

1.  T618I-Mutated Colony Stimulating Factor 3 Receptor in Chronic Neutrophilic Leukemia and Chronic Myelomonocytic Leukemia Patients who Underwent Allogeneic Stem Cell Transplantation.

Authors:  Sung-Eun Lee; Irene Jo; Woori Jang; Yonggoo Kim; Kyungja Han; Myungshin Kim
Journal:  Ann Lab Med       Date:  2015-04-01       Impact factor: 3.464

Review 2.  What's different about atypical CML and chronic neutrophilic leukemia?

Authors:  Kim-Hien T Dao; Jeffrey W Tyner
Journal:  Hematology Am Soc Hematol Educ Program       Date:  2015

3.  An International MDS/MPN Working Group's perspective and recommendations on molecular pathogenesis, diagnosis and clinical characterization of myelodysplastic/myeloproliferative neoplasms.

Authors:  Tariq I Mughal; Nicholas C P Cross; Eric Padron; Ramon V Tiu; Michael Savona; Luca Malcovati; Raoul Tibes; Rami S Komrokji; Jean-Jacques Kiladjian; Guillermo Garcia-Manero; Attilio Orazi; Ruben Mesa; Jaroslaw P Maciejewski; Pierre Fenaux; Raphael Itzykson; Ghulam Mufti; Eric Solary; Alan F List
Journal:  Haematologica       Date:  2015-09       Impact factor: 9.941

4.  Targeted next-generation sequencing identifies clinically relevant mutations in patients with chronic neutrophilic leukemia at diagnosis and blast crisis.

Authors:  S E Langabeer; K Haslam; J Kelly; J Quinn; R Morrell; E Conneally
Journal:  Clin Transl Oncol       Date:  2017-07-31       Impact factor: 3.405

Review 5.  Chronic neutrophilic leukemia: new science and new diagnostic criteria.

Authors:  Natasha Szuber; Ayalew Tefferi
Journal:  Blood Cancer J       Date:  2018-02-13       Impact factor: 11.037

Review 6.  Allogeneic Hematopoietic Stem Cell Transplantation for Mixed or Overlap Myelodysplastic/Myeloproliferative Disorders.

Authors:  Argiris Symeonidis; Spiros Chondropoulos; Evgenia Verigou; Vasileios Lazaris; Alexandra Kourakli; Panagiotis Tsirigotis
Journal:  Front Oncol       Date:  2022-08-05       Impact factor: 5.738

Review 7.  Atypical chronic myeloid leukaemia - a rare subtype of myelodysplastic/myeloproliferative neoplasm.

Authors:  Joanna E Drozd-Sokołowska; Anna Waszczuk-Gajda; Krzysztof Mądry; Jadwiga Dwilewicz-Trojaczek
Journal:  Contemp Oncol (Pozn)       Date:  2018-04-03

Review 8.  Atypical Chronic Myeloid Leukemia: Where Are We Now?

Authors:  Elena Crisà; Maura Nicolosi; Valentina Ferri; Chiara Favini; Gianluca Gaidano; Andrea Patriarca
Journal:  Int J Mol Sci       Date:  2020-09-18       Impact factor: 5.923
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.